SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Reforms and initiatives in Scotland in recent years to encourage the prescribing of generic drugs, their influence and implications for other countries
10 references·1 citing·35 second hop
Reforms and initiatives in Scotland in recent years to encourage the prescribing of generic drugs, their influence and implications for other countries (2013)Reforms and initiatives in Scotland in re…The impact of pharmaceutical pricing and reimbursement policies on generics uptake: implementation of policy options on generics in 29 European countries─an overview (2012)The impact of pharmaceutical …Ongoing measures to enhance the efficiency of prescribing of proton pump inhibitors and statins in The Netherlands: influence and future implications (2012)Ongoing measures to enhance t…Policies to Enhance Prescribing Efficiency in Europe: Findings and Future Implications (2011)Policies to Enhance Prescribi…Cochrane Database of Systematic Reviews (2011)Cochrane Database of Systemat…Use of Generics—A Critical Cost Containment Measure for All Healthcare Professionals in Europe? (2010)Use of Generics—A Critical Co…Ongoing pharmaceutical reforms in France (2010)Ongoing pharmaceutical reform…Generic and therapeutic substitutions in the UK: are they a good thing? (2010)Generic and therapeutic subst…Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications (2010)Comparing policies to enhance…Soft regulations in pharmaceutical policy making (2009)Soft regulations in pharmaceu…Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance (2009)Multifaceted national and reg…The prescribing of generic medicines in Nigeria: knowledge, perceptions and attitudes of physicians (2015)The prescribing of generic me…Estonia: Health System Review. (2013)Institutionalized Organizations: Formal Structure as Myth and Ceremony (1977)The Audit Society: Rituals of Verification (1998)The Audit Society: Rituals of Verification (1999)Influence of demand-side measures to enhance renin–angiotensin prescribing efficiency in Europe: implications for the future (2011)Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers (2010)The ‘Wise List’– A Comprehensive Concept to Select, Communicate and Achieve Adherence to Recommendations of Essential Drugs in Ambulatory Care in Stockholm (2011)What do primary care patients think about generic drugs? (2005)Clinical Equivalence of Generic and Brand-Name Drugs Used in Cardiovascular Disease (2008)European Society for Organ Transplantation Advisory Committee Recommendations on Generic Substitution of Immunosuppressive Drugs (2011)Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review (2015)The Swedish Council on Technology Assessment in Health Care (1989)Health systems in transition. (2010)Are new models needed to optimize the utilization of new medicines to sustain healthcare systems? (2014)Diffusion of Innovations 1 (2019)Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis (2008)European countries with small populations can obtain low prices for drugs: Lithuania as a case history (2011)Multiple initiatives continue to enhance the prescribing efficiency for the proton pump inhibitors and statins in Scotland (2012)Systematic review and meta-analysis (2019)Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies (2006)Sustaining Generic Medicines Markets in Europe (2006)THE WORLD MEDICINES SITUATION 2011 (2011)Policy options for pharmaceutical pricing and purchasing: issues for low- and middle-income countries (2014)Definition and Classification of Generic Drugs Across the World (2015)European Healthcare Policies for Controlling Drug Expenditure (2003)Patients’ attitudes towards and experiences of generic drug substitution in Norway (2006)Patients’ Perceptions Of Generic Medications (2009)Demand-side policies to encourage the use of generic medicines: an overview (2013)Fixed dose drug combinations – are they pharmacoeconomically sound? Findings and implications especially for lower- and middle-income countries (2020)Pharmaceutical policies in European countries in response to the global financial crisis (2011)Policies to promote use of generic medicines in low and middle income countries: A review of published literature, 2000–2010 (2012)Medicine Shortages: Gaps Between Countries and Global Perspectives (2019)The Efficacy of Cognitive Behavioral Therapy: A Review of Meta-analyses (2012)Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of eating disorders (2014)Effects of music interventions on stress-related outcomes: a systematic review and two meta-analyses (2019)
this work references cited by second hop

References

  • 2011Cochrane Database of Systematic Reviews4,664 cited
  • 2010Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications153 cited
  • 2009Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance150 cited
  • 2010Generic and therapeutic substitutions in the UK: are they a good thing?149 cited
  • 2012The impact of pharmaceutical pricing and reimbursement policies on generics uptake: implementation of policy options on generics in 29 European countries─an overview115 cited
  • 2011Policies to Enhance Prescribing Efficiency in Europe: Findings and Future Implications113 cited
  • 2010Ongoing pharmaceutical reforms in France108 cited
  • 2009Soft regulations in pharmaceutical policy making97 cited
  • 2012Ongoing measures to enhance the efficiency of prescribing of proton pump inhibitors and statins in The Netherlands: influence and future implications97 cited
  • 2010Use of Generics—A Critical Cost Containment Measure for All Healthcare Professionals in Europe?93 cited

Cited by

  • 2015The prescribing of generic medicines in Nigeria: knowledge, perceptions and attitudes of physicians79 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work